2:
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW.
Ann Surg Oncol. 2007 Jan;14(1):14-24.
PMID: 17072676 [PubMed - indexed for MEDLINE]
Related Articles
20:
Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs).
Rutkowski P, Nowecki ZI, Debiec-Rychter M, Grzesiakowska U, Michej W, Woźniak A, Siedlecki JA, Limon J, vel Dobosz AJ, Kakol M, Osuch C, Ruka W.
J Cancer Res Clin Oncol. 2007 Sep;133(9):589-97. Epub 2007 Apr 26.
PMID: 17458563 [PubMed - indexed for MEDLINE]
Related Articles